Life Science Fundraising & Investment
25-26 March 2026,
Lisbon Congress Centre, Lisbon, Portugal

Fusing AI & Digital Innovation with Pharma

Connecting Pharma with Digital Tech Innovators
Improving R&D, Clinical Trials & Patient Outcomes
Defining the Future of Pharma

"LSX has evolved into a trusted partnership which helps us connect with innovative and exciting life science companies"
- Senior Director-Business Development Strategic Operations and Intelligence, Lilly

Download the Brochure Download the 2025 Attendee List

What is Pharmatech Leaders?

LSX Europe's Pharmatech Leaders brings together pharmaceutical executives, digital health innovators, and venture capital leaders to explore the transformative power of AI, digital therapeutics, and emerging technologies in drug discovery and development.

Join industry pioneers from Novo Nordisk, Merck, Servier, and Jazz Pharmaceuticals as they share insights on digital transformation strategies, AI integration, clinical trial optimisation, and precision medicine advancement.

This specialised program connects pharmatech decision-makers with cutting-edge solutions that are reshaping patient outcomes and accelerating therapeutic innovation across the global pharmaceutical ecosystem.

Join us to 'Connect with Purpose'.

Meet our 2026 Pharmatech Speakers

Gregoire Guillet

Chief Business & Value Officer at WeHealth

Servier

Ioanna Mylonaki

Managing Partner

Untethered Ventures

Jim O’Donoghue

President

S3 Connected Health

Pedro Costa

CSO

Interventional Systems

Ole Henrik Bang-Andreasen

Principal

Avant Bio

Loucif Ouyahia

Global Head of Digital Healthcare

Jazz Pharmaceuticals

Katariina Kronholm

Head of Life Sciences & Data Partnerships

Elekta

Bibi Sattar Marques

Partner

Buenavista Equity Partners

Alejo Costa Ribalta

Partner

CRB Health Tech SGEIC

Oleg Chervonnyi

Investment Manager - Venture Capital

Beiersdorf

Volker Hirsch

Partner

Brainworks

Jerry Wu

Managing Director

LongRiver Investments

Meet the speakers

Pharmatech innovation, partnerships & investment

Pharmatech leaders is where pharma meets AI & digital innovators to help pharma accelerate their digital transformation journey.

LSX pharmatech speaker addresses the panel

AI-Driven Drug Discovery & Development

Transforming pharmaceutical R&D through artificial intelligence and machine learning

Sessions explore how AI technologies are revolutionizing drug discovery, from literature analysis and virtual chemistry applications to digital twin modeling for drug interactions. Industry leaders from Novo Nordisk, Merck, and Jazz Pharmaceuticals share insights on implementing AI beyond technology adoption, addressing organizational behaviour change and workflow integration challenges that determine AI success in pharmaceutical settings.

Pharmatech exhibitor explains their product to an attendee

Digital Clinical Operations & Patient Engagement

Modernising clinical trials and patient care through digital innovation

Expert panels examine digital transformation in clinical trial management, covering participant recruitment, monitoring, data consolidation, and treatment adherence improvements. Sessions address building patient trust in AI-powered healthcare solutions, precision medicine advancement, and how digital technologies can enhance traditional pharmaceutical therapies to improve patient outcomes and medication adherence.

Strategic Partnerships & Investment in Pharmatech Innovation

Fostering collaboration between pharma, startups, and venture capital

Programming focuses on venture capital's role in driving pharmatech innovation, corporate venture capital investment strategies for AI and digital health startups, and creating win-win collaborations between pharmaceutical companies and external innovators. Sessions explore the balance between internal development and external partnerships, transatlantic market differences, and regulatory considerations for successful pharmatech implementation.